Close Cookies on this website We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies. Continue Find out more Media Business Development Select country Home About us Products R&D Investors Responsibility Patient Support Careers View the Press Release Download the Presentation Download the Shire IR App LSE Price £53.60 -- NASDAQ Price $256.00 -4.53 10 Oct 2014 At least 15 minutes delayed Q2 2014 Results 2013 Annual Report Share price charting tool Shire has a wide range of products on the market and will ensure that it can make more products available in the future. Search by keyword Search by country Please select World Wide Argentina Australia Austria Belgium Brazil Bulgaria Canada Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hong Kong Hungary Iceland Indonesia Ireland Israel Italy Japan Korea Latvia Liechtenstein Lithuania Luxembourg Macau Malaysia Malta Mexico Netherlands New Zealand Norway Paraguay Philippines Poland Portugal Romania Russia Saudi Arabia Singapore Slovak Republic Slovenia South Africa South Korea Spain Sweden Switzerland Taiwan Thailand Turkey UK USA Uruguay Colombia View all products 09 Oct 2014 Shire Provides Regulatory Update on SHP 465, Investigational Compound ... 01 Oct 2014 FORM 8 (DD) - Shire plc 01 Oct 2014 FORM 8 (DD) - Shire plc View all news Shire Opposes Misuse, Abuse and Diversion of Prescription ADHD Medicines. Read more here. Sitemap Contact Us News Feed Disclaimer Legal Notice Privacy Policy Cookies Safe Harbor Policy © Shire 2014 Delivered by global3digital Designed by Bostock and Pollitt